Phase 4 — Structural Tissue Repair

Rebuilding connective tissue collagen quality. The slowest phase because it depends on collagen turnover rates. Skin: ~2 years. Tendon: ~2 years with loading. Cartilage: essentially irreplaceable.

What's Actually Being Repaired

Not collagen quantity — collagen quality. The problem in EDS is collagen that is:

• Inadequately hydroxylated (prolyl/lysyl hydroxylase impaired by 4-HNE)
• Poorly cross-linked (lysyl oxidase impaired by 4-HNE adducts)
• Assembled in a pro-inflammatory, MMP-elevated environment that degrades it before adequate accumulation

With Phase 0 restoring the enzyme function, Phase 1 reducing the inflammatory environment, and Phase 4 providing direct precursors and synthesis stimulators, the new collagen synthesized after Phase 0–3 is structurally superior to what it replaces.

The Collagen Synthesis Pathway

Requires simultaneous functional enzymes AND precursor availability:

• Prolyl hydroxylase: Fe²⁺ + ascorbate (vitamin C) — both must be present
• Lysyl hydroxylase: Fe²⁺ + ascorbate — same
• Lysyl oxidase (cross-linking): Cu²⁺ + B6 — copper and B6
• Procollagen secretion: Mg²⁺, zinc for chaperone function
• Matrix metalloproteinase regulation: determines net accumulation rate

→ Full detail: [[Collagen Synthesis Pathway]]

Interventions — Weeks 8 through Years

Collagen Peptides — 10–15g daily

Provides hydroxyproline directly — the amino acid the body cannot synthesize quickly enough under oxidative stress to supply normal collagen synthesis. Standard dietary protein provides proline but not hydroxyproline. The clinical evidence for supplemental collagen peptides increasing collagen synthesis markers is reasonably consistent.

L-Lysine — 1–2g daily

Direct cross-linking precursor. Competes with oxidized lysine residues for incorporation into collagen structure. Restoring unmodified lysine availability improves cross-link quality.

Centella Asiatica — 500mg twice daily

Asiaticoside and madecassoside specifically upregulate collagen type I gene transcription in connective tissue fibroblasts. This is a direct transcriptional stimulus to collagen synthesis — not a cofactor or precursor effect but a gene expression effect. Traditional wound-healing use confirmed by cell biology mechanism.

Pine Bark OPCs (Pycnogenol equivalent) — 100–200mg daily

Oligomeric proanthocyanidins physically bind to collagen and elastin fibers, protecting them from MMP-1, MMP-2, MMP-9 degradation. This is structural protection of existing matrix — reducing the degradation side of the synthesis/degradation balance. Historical discovery: Jacques Cartier's crew cured of scurvy by Iroquois Annedda pine bark preparation in 1535 CE — the original observation of collagen-protective chemistry.

Orthosilicic Acid — 10–15mg silicon daily

Bioavailable form of silicon (Si(OH)₄). Directly stimulates collagen type I synthesis in fibroblasts through incompletely characterized but consistently documented mechanisms. Available as horsetail extract or stabilized orthosilicic acid supplement.

Manganese — 5mg daily

Cofactor for prolidase — the enzyme recycling proline from degraded collagen for resynthesis. Without functional prolidase, degraded collagen's proline content is lost rather than recycled, requiring dietary proline to cover the gap. Manganese deficiency specifically impairs this recycling efficiency.

Resistance Exercise — Non-Negotiable

No supplement substitutes for mechanical loading as the primary collagen synthesis signal in tendons and ligaments.

Mechanical loading activates tenocytes and fibroblasts through integrin signaling, promoting collagen type I synthesis specifically in load-bearing structures. The growth factor signaling cascade (IGF-1, TGF-β) released by mechanically stimulated connective tissue cells is the primary driver of tendon and ligament collagen remodeling.

The risk of progressive joint damage in EDS from under-loading (to avoid injury) is comparable to the risk from over-loading. Appropriate progressive loading under supervision is required, not optional.

Connections

• [[Phase 0 - Source Control and Redox]] — restores enzyme function prerequisite
• [[Collagen Synthesis Pathway]] — full biochemistry
• [[EDS-MCAS-Eczema Cluster]] — the primary condition
• [[Efferocytosis Failure]] — C1q connection (shared enzyme requirement)
• [[Phase 5 - Adipose Remodeling]] — the reservoir that's still releasing inflammatory signals